IRAK1 and acute myeloid leukemia: In turn, enhanced IL-1β and other members of its signaling pathway, including IL-1RAP, MyD88, IRAK1, IRAK4 and TRAF6, have been involved in AML and/or myelodysplastic syndrome (MDS)6–14.